A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Ocellaris Pharma, Inc.
Ocellaris Pharma, Inc.
Fusion Pharmaceuticals Inc.
Incyte Corporation
Actym Therapeutics, Inc.
Telix Pharmaceuticals (Innovations) Pty Limited
Turnstone Biologics, Corp.
Seagen Inc.
Sotio Biotech Inc.
Aminex Therapeutics, Inc.
Astellas Pharma Inc
Molecular Templates, Inc.
Merck Sharp & Dohme LLC
Advaxis, Inc.
Rubius Therapeutics
Repertoire Immune Medicines
Eli Lilly and Company
Incyte Corporation
University of California, San Francisco
CureOne
University Health Network, Toronto
BIND Therapeutics